Matches in Wikidata for { <http://www.wikidata.org/entity/Q91901565> ?p ?o ?g. }
Showing items 1 to 66 of
66
with 100 items per page.
- Q91901565 description "2019 թվականի հուլիսի 12-ին հրատարակված գիտական հոդված" @default.
- Q91901565 description "artículu científicu espublizáu en xunetu de 2019" @default.
- Q91901565 description "scientific article published on 12 July 2019" @default.
- Q91901565 description "wetenschappelijk artikel" @default.
- Q91901565 description "наукова стаття, опублікована 12 липня 2019" @default.
- Q91901565 name "Comparison of the efficacy and safety of once-daily insulin degludec/insulin aspart (IDegAsp) and long-acting second-generation basal insulin (insulin degludec and insulin glargine 300 units/mL) in insulin-naïve Japanese adults with type 2 diabetes:" @default.
- Q91901565 name "Comparison of the efficacy and safety of once-daily insulin degludec/insulin aspart (IDegAsp) and long-acting second-generation basal insulin (insulin degludec and insulin glargine 300 units/mL) in insulin-naïve Japanese adults with type 2 diabetes:" @default.
- Q91901565 type Item @default.
- Q91901565 label "Comparison of the efficacy and safety of once-daily insulin degludec/insulin aspart (IDegAsp) and long-acting second-generation basal insulin (insulin degludec and insulin glargine 300 units/mL) in insulin-naïve Japanese adults with type 2 diabetes:" @default.
- Q91901565 label "Comparison of the efficacy and safety of once-daily insulin degludec/insulin aspart (IDegAsp) and long-acting second-generation basal insulin (insulin degludec and insulin glargine 300 units/mL) in insulin-naïve Japanese adults with type 2 diabetes:" @default.
- Q91901565 prefLabel "Comparison of the efficacy and safety of once-daily insulin degludec/insulin aspart (IDegAsp) and long-acting second-generation basal insulin (insulin degludec and insulin glargine 300 units/mL) in insulin-naïve Japanese adults with type 2 diabetes:" @default.
- Q91901565 prefLabel "Comparison of the efficacy and safety of once-daily insulin degludec/insulin aspart (IDegAsp) and long-acting second-generation basal insulin (insulin degludec and insulin glargine 300 units/mL) in insulin-naïve Japanese adults with type 2 diabetes:" @default.
- Q91901565 P1433 Q91901565-C2198A0E-6136-41C7-893A-8350B43543D3 @default.
- Q91901565 P1476 Q91901565-C29DA9A0-9219-47F9-A29C-709B896243BF @default.
- Q91901565 P2093 Q91901565-0AB2B8F6-5917-4C9C-9264-2BC9F87F7B86 @default.
- Q91901565 P2093 Q91901565-16AD6A76-906B-4A2B-A2F8-CDE8B19C4F34 @default.
- Q91901565 P2093 Q91901565-18595D38-2230-48EE-8287-DA52C62604F9 @default.
- Q91901565 P2093 Q91901565-224C78DC-57CF-4574-8AC0-CBA745AC4790 @default.
- Q91901565 P2093 Q91901565-804393B4-C4C5-4AA2-B450-275CC25D687F @default.
- Q91901565 P2093 Q91901565-A89219AC-AFF7-43EF-8F5A-588E1042338F @default.
- Q91901565 P2093 Q91901565-B02183A3-6701-4C60-90B7-4709C685B21F @default.
- Q91901565 P2093 Q91901565-C337CDC4-11B1-4E98-B637-77713FAACE51 @default.
- Q91901565 P2093 Q91901565-C49A347D-7E46-44EF-83CC-797E728E7D86 @default.
- Q91901565 P2093 Q91901565-C552795F-AC9E-4D74-B698-A89A10E76813 @default.
- Q91901565 P2093 Q91901565-D64ACEE3-F7D9-42A9-BE00-D0554F75FFA0 @default.
- Q91901565 P2093 Q91901565-DEF9E0A6-0BB8-4583-9B82-85BA9B98B170 @default.
- Q91901565 P2093 Q91901565-ECAD5B2A-404B-4D78-B9F1-269C0F5286E4 @default.
- Q91901565 P2093 Q91901565-FDCC0333-5B80-4D32-8A64-0742B2F501B1 @default.
- Q91901565 P2860 Q91901565-1B18A439-C794-4230-889D-0250FA21BFE7 @default.
- Q91901565 P304 Q91901565-5E9C2142-065A-4D95-B0AA-13033E0DEC87 @default.
- Q91901565 P31 Q91901565-45152688-8813-4CBE-BF44-8C77730BA418 @default.
- Q91901565 P356 Q91901565-995CD0C5-7B48-410B-9D3A-E67CA795A23F @default.
- Q91901565 P433 Q91901565-F8CD1181-B7BF-4A71-9088-04A3CDF34A3C @default.
- Q91901565 P478 Q91901565-93C6F014-34C4-494D-9F7D-8EDDF7799A12 @default.
- Q91901565 P577 Q91901565-0C0099CE-200C-47EA-8F38-E3B2AD2D74F6 @default.
- Q91901565 P698 Q91901565-CC05EDD3-96A9-4152-BCA0-5BD693979384 @default.
- Q91901565 P921 Q91901565-F0D43F33-8031-46EB-98D0-B909D920C772 @default.
- Q91901565 P921 Q91901565-F11C60A7-1F11-428D-9E24-066011A6A392 @default.
- Q91901565 P356 ENDOCRJ.EJ19-0179 @default.
- Q91901565 P698 31308304 @default.
- Q91901565 P1433 Q5376304 @default.
- Q91901565 P1476 "Comparison of the efficacy and safety of once-daily insulin degludec/insulin aspart (IDegAsp) and long-acting second-generation basal insulin (insulin degludec and insulin glargine 300 units/mL) in insulin-naïve Japanese adults with type 2 diabetes: a pilot, randomized, controlled study" @default.
- Q91901565 P2093 "Ayaka Hokamura" @default.
- Q91901565 P2093 "Eiichi Araki" @default.
- Q91901565 P2093 "Kae Otsu" @default.
- Q91901565 P2093 "Kenro Nishida" @default.
- Q91901565 P2093 "Masaji Sakaguchi" @default.
- Q91901565 P2093 "Norio Ishii" @default.
- Q91901565 P2093 "Ryohei Yoshimura" @default.
- Q91901565 P2093 "Seiya Shimoda" @default.
- Q91901565 P2093 "Shinji Ichimori" @default.
- Q91901565 P2093 "Shinsuke Iwashita" @default.
- Q91901565 P2093 "Taiji Sekigami" @default.
- Q91901565 P2093 "Toshihiko Nishiyama" @default.
- Q91901565 P2093 "Wakana Sakamoto" @default.
- Q91901565 P2093 "Yasuto Matsuo" @default.
- Q91901565 P2860 Q33585669 @default.
- Q91901565 P304 "745-752" @default.
- Q91901565 P31 Q13442814 @default.
- Q91901565 P356 "10.1507/ENDOCRJ.EJ19-0179" @default.
- Q91901565 P433 "8" @default.
- Q91901565 P478 "66" @default.
- Q91901565 P577 "2019-07-12T00:00:00Z" @default.
- Q91901565 P698 "31308304" @default.
- Q91901565 P921 Q3025883 @default.
- Q91901565 P921 Q417317 @default.